SCHEMBL20846973

SCHEMBL20846973

O=C1/C(=C/c2ccc(O)c(O)c2)SC(=S)N1Nc1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 12/20 1.00
▸ KMT2A Q03164 11/20 1.00
▸ MEN1 O00255 10/20 1.00
▸ ALDH1A1 P00352 8/20 1.00
▸ GAA P10253 6/20 1.00
▸ TDP1 Q9NUW8 5/20 1.00
▸ HTT P42858 5/20 1.00
▸ MAPK1 P28482 5/20 1.00
▸ RECQL P46063 3/20 1.00
▸ KDM4E B2RXH2 3/20 1.00
▸ NSD2 O96028 2/20 1.00
▸ JAK2 O60674 1/20 1.00
▸ NPY2R P49146 1/20 1.00
▸ BLM P54132 1/20 1.00
▸ POLB P06746 5/20 0.77
▸ L3MBTL1 Q9Y468 5/20 0.77
▸ OPRK1 P41145 1/20 0.77
▸ NPSR1 Q6W5P4 2/20 0.72
▸ NPC1 O15118 1/20 0.72
▸ THRB P10828 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2403957 0.79 HSPD1 (0.81) MAPTKMT2AMEN1ALDH1A1GAA
SCHEMBL2403963 0.79 HSPD1 (0.81) MAPTKMT2AMEN1ALDH1A1GAA
SCHEMBL2403960 0.79 HSPD1 (0.81) MAPTKMT2AMEN1ALDH1A1GAA
SCHEMBL2492218 0.77 MEN1 (0.74) MAPTKMT2AMEN1ALDH1A1GAA
SCHEMBL14788065 0.77 MEN1 (0.74) MAPTKMT2AMEN1ALDH1A1GAA
SCHEMBL2492219 0.77 MEN1 (0.74) MAPTKMT2AMEN1ALDH1A1GAA
SCHEMBL5284210 0.76 HSD17B3 (0.78) MAPTKMT2AMEN1ALDH1A1GAA
SCHEMBL14788079 0.76 HSPD1 (0.64) MAPTKMT2AMEN1ALDH1A1GAA
SCHEMBL5284212 0.76 HSD17B3 (0.78) MAPTKMT2AMEN1ALDH1A1GAA
SCHEMBL2532230 0.76 HSPD1 (0.64) MAPTKMT2AMEN1ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230165815-A1 ROLES OF MODULATORS OF INTERSECTIN-CDC42 SIGNALING IN ALZHEIMER?S DISEASE Lu, Qun (US) 2023-06-01 — — US disclosed
US-20190091184-A1 ROLES OF MODULATORS OF INTERSECTIN-CDC42 SIGNALING IN ALZHEIMER'S DISEASE LU, QUN 2019-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230165815-A1 ROLES OF MODULATORS OF INTERSECTIN-CDC42 SIGNALING IN ALZHEIMER?S DISEASE CDC42, MDN1, GAP43 MAPT 267/4885KMT2A 4297/4885MEN1 3675/4885
US-20190091184-A1 ROLES OF MODULATORS OF INTERSECTIN-CDC42 SIGNALING IN ALZHEIMER'S DISEASE CDC42, MDN1, HASPIN MAPT 326/4885KMT2A 4371/4885MEN1 3739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback